litlas
Log inCreate account

Gary S. Sachs

Active 1992–2025

Also published as
Gary S Sachs · GARY S. SACHS
83
Papers
20,797
Citations
75
h-index
80
i10-index

Citations

Citations per year for Gary S. Sachs1986: 1 citations1988: 1 citations1994: 2 citations1996: 3 citations1998: 3 citations1999: 8 citations2000: 23 citations2001: 33 citations2002: 87 citations2003: 110 citations2004: 107 citations2005: 144 citations2006: 196 citations2007: 189 citations2008: 225 citations2009: 217 citations2010: 225 citations2011: 228 citations2012: 204 citations2013: 186 citations2014: 182 citations2015: 160 citations2016: 177 citations2017: 109 citations2018: 97 citations2019: 367 citations2020: 336 citations2021: 242 citations2022: 188 citations2023: 155 citations2024: 211 citations2025: 123 citations2026: 2 citations1987: no citations, so this year is not shown1989–1993: no citations, so these years are not shown1995: no citations, so this year is not shown1997: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,637 citing papers, 28.8% of this breakdownUnited Kingdom: 509 citing papers, 9% of this breakdownCanada: 366 citing papers, 6.4% of this breakdownItaly: 306 citing papers, 5.4% of this breakdownSpain: 261 citing papers, 4.6% of this breakdownGermany: 249 citing papers, 4.4% of this breakdownAustralia: 226 citing papers, 4% of this breakdownNetherlands: 148 citing papers, 2.6% of this breakdownFrance: 142 citing papers, 2.5% of this breakdownSweden: 142 citing papers, 2.5% of this breakdownChina: 134 citing papers, 2.3% of this breakdownBrazil: 119 citing papers, 2.1% of this breakdown
0%28.8%Other 25.4%

Institutions

Fields

  • Medicine67.8%
  • Psychology10.8%
  • Biochemistry, Genetics and Molecular Biology9.6%
  • Neuroscience9.5%
  • Health Professions0.5%
  • Computer Science0.3%
  • Other1.5%

Topics

  • Bipolar Disorder and Treatment21.6%
  • Schizophrenia research and treatment9.6%
  • Treatment of Major Depression6.3%
  • Tryptophan and brain disorders4.7%
  • Electroconvulsive Therapy Studies4.1%
  • Genetic Associations and Epidemiology2.3%
  • Other51.4%

Coauthors

All papers

Open in search
  1. Development and Validation of a Screening Instrument for Bipolar Spectrum Disorder: The Mood Disorder Questionnaire

    Authors: Robert M. A. Hirschfeld, Janet B. W. Williams, Robert L. Spitzer, Joseph R. Calabrese, Laurie M. Flynn, Paul E. Keck, Lydia Lewis, Susan L. McElroy, Robert M. Post, Daniel Rapport, James M. Russell, Gary S. Sachs, John Zajecka - American Journal of Psychiatry 2000 cited by 1,527

  2. The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders

    Authors: Isabella Pacchiarotti, David J. Bond, Ross J. Baldessarini, Willem A. Nolen, Heinz Grunze, Rasmus Wentzer Licht, Robert M. Post, Michael Berk, Guy M. Goodwin, Gary S. Sachs, Leonardo Tondo, Robert L. Findling, Eric A. Youngstrom, Mauricio Tohen, Juan Undurraga, Ana González‐Pinto, Joseph F. Goldberg, Ayşegül Yıldız, Lori L. Altshuler, Joseph R. Calabrese, Philip B. Mitchell, Michael E. Thase, Athanasios Koukopoulos, Francesc Colom, Mark A. Frye, Gin S. Malhi, Konstantinos Ν. Fountoulakis, Gustavo Vázquez, Roy H. Perlis, Terence A. Ketter, Frederick Cassidy, Hagop S. Akiskal, Jean-Michel Azorin, Marc Valentí, Diego Hidalgo‐Mazzei, Beny Lafer, Tadafumi Kato, Lorenzo Mazzarini, Anabel Martínez‐Arán, Gordon Parker, Daniel Souery, Ayşegül Özerdem, Susan L. McElroy, Paolo Girardi, Michael Bauer, Lakshmi N. Yatham, Carlos A. Zarate, Andrew A. Nierenberg, Boris Birmaher, Shigenobu Kanba, Rif S. El‐Mallakh, Alessandro Serretti, Zoltán Rihmer, Allan H. Young, Georgios D. Kotzalidis, Glenda MacQueen, Charles L. Bowden, S. Nassir Ghaemi, Carlos López‐Jaramillo, Janusz Rybakowski, Kyooseob Ha, Giulio Perugi, Siegfried Kasper, Jay D. Amsterdam, Robert M. A. Hirschfeld, Flávio Kapczinski, Eduard Vieta - American Journal of Psychiatry 2013 cited by 754

  3. Efficacy and Safety of Lumateperone for Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder: A Phase 3 Randomized Placebo-Controlled Trial

    Authors: Joseph R. Calabrese, Suresh Durgam, Andrew Satlin, Kimberly E. Vanover, Robert E. Davis, Richard Chen, Susan G Kozauer, Sharon Mates, Gary S. Sachs - American Journal of Psychiatry 2021 cited by 109

  4. The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders

    Authors: Mauricio Tohen, Ellen Frank, Charles L. Bowden, Francesc Colom, S. Nassir Ghaemi, Lakshmi N. Yatham, Gin S. Malhi, Joseph R. Calabrese, Willem A. Nolen, Eduard Vieta, Flávio Kapczinski, Guy M. Goodwin, Trisha Suppes, Gary S Sachs, KN Roy Chengappa, Heinz Grunze, Philip B. Mitchell, Shigenobu Kanba, Michael Berk - Bipolar Disorders 2009 cited by 507

  5. Adjunctive Cariprazine for the Treatment of Patients With Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study

    Authors: Gary S. Sachs, Paul Yeung, Ludmyla Rekeda, Arifulla Khan, Julie Adams, Maurizio Fava - American Journal of Psychiatry 2023 cited by 58

  6. Predictors of Recurrence in Bipolar Disorder: Primary Outcomes From the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

    Authors: Roy H. Perlis, Michael J. Ostacher, Jayendra K. Patel, Lauren B. Marangell, Hongwei Zhang, Stephen R. Wisniewski, Terence A. Ketter, David J. Miklowitz, Michael W. Otto, L. Gyulai, Noreen A. Reilly-Harrington, Andrew A. Nierenberg, Gary S. Sachs, Michael E. Thase - American Journal of Psychiatry 2006 cited by 690

  7. Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression

    Authors: Gary S. Sachs, Andrew A. Nierenberg, Joseph R. Calabrese, Lauren B. Marangell, Stephen R. Wisniewski, L. Gyulai, Edward S. Friedman, Charles L. Bowden, Mark D. Fossey, Michael J. Ostacher, Terence A. Ketter, Jayendra K. Patel, Péter Hauser, Daniel Rapport, James M. Martinez, Michael H. Allen, David J. Miklowitz, Michael W. Otto, Ellen B. Dennehy, Michael E. Thase - New England Journal of Medicine 2007 cited by 926

  8. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder

    Authors: Manuel A. R. Ferreira, Michael O‘Donovan, Yan Meng, Ian Jones, Douglas M. Ruderfer, Lisa Jones, Jinbo Fan, George Kirov, Roy H. Perlis, Elaine Green, Jordan W. Smoller, Detelina Grozeva, Jennifer Stone, Ivan Nikolov, Kimberly Chambert, Marian L. Hamshere, Vishwajit L. Nimgaonkar, Valentina Moskvina, Michael E. Thase, Sian Caesar, Gary S Sachs, Jennifer Franklin, Katherine Gordon‐Smith, Kristin G. Ardlie, Stacey Gabriel, Christine Fraser, Brendan Blumenstiel, Matthew DeFelice, Gerome Breen, Michael Gill, Derek W. Morris, Amanda Elkin, Walter Muir, Kevin A. McGhee, Richard Williamson, Donald J. MacIntyre, Alan Maclean, David St Clair, Michelle Robinson, M. Van Beck, Ana Carla Pereira, Radhika Kandaswamy, Andrew McQuillin, David Collier, Nicholas Bass, Allan H. Young, Jacob Lawrence, I. Nicol Ferrier, Adebayo Anjorin, Anne Farmer, David Curtis, Edward M. Scolnick, Peter McGuffin, Mark J. Daly, Aiden Corvin, Peter Holmans, Douglas Blackwood, Hugh Gurling, Michael J. Owen, Shaun Purcell, Pamela Sklar, Nick Craddock - Nature Genetics 2008 cited by 1,258

  9. Cariprazine Treatment of Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Phase 3 Study

    Authors: Willie Earley, Maria Victoria Burgess, Ludmyla Rekeda, Regan Dickinson, B. Szatmári, György Németh, Roger S. McIntyre, Gary S. Sachs, Lakshmi N. Yatham - American Journal of Psychiatry 2019 cited by 155

  10. Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD)

    Authors: Gary S Sachs, Michael E. Thase, Michael W. Otto, Mark S. Bauer, David J. Miklowitz, Stephen R. Wisniewski, Philip W. Lavori, Barry D. Lebowitz, Mathew Rudorfer, Ellen Frank, Andrew A. Nierenberg, Maurizio Fava, Charles L. Bowden, Terence A. Ketter, Lauren B. Marangell, Joseph R. Calabrese, David J. Kupfer, Jerrold F. Rosenbaum - Biological Psychiatry 2003 cited by 542

  11. Olanzapine Versus Lithium in the Maintenance Treatment of Bipolar Disorder: A 12-Month, Randomized, Double-Blind, Controlled Clinical Trial

    Authors: Mauricio Tohen, W. Greil, Joseph R. Calabrese, Gary S. Sachs, Lakshmi N. Yatham, Bruno Müller Oerlinghausen, Athanasios Koukopoulos, Giovanni Battista Cassano, Heinz Grunze, Rasmus Wentzer Licht, Liliana Dell’Osso, Angela R. Evans, Richard C. Risser, Robert W. Baker, Heidi M. Crane, M. Dossenbach, Charles L. Bowden - American Journal of Psychiatry 2005 cited by 366

  12. Psychosocial Treatments for Bipolar Depression

    Authors: David J. Miklowitz, Michael W. Otto, Ellen Frank, Noreen A. Reilly-Harrington, Stephen R. Wisniewski, Jane N. Kogan, Andrew A. Nierenberg, Joseph R. Calabrese, Lauren B. Marangell, L. Gyulai, Mako Araga, Jodi M. Gonzalez, Edwin Shirley, Michael E. Thase, Gary S. Sachs - Archives of General Psychiatry 2007 cited by 537

  13. Long-Term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD)

    Authors: Roy H. Perlis, Sachiko Miyahara, Lauren B. Marangell, Stephen R. Wisniewski, Michael J. Ostacher, Melissa P. DelBello, Charles L. Bowden, Gary S Sachs, Andrew A. Nierenberg - Biological Psychiatry 2004 cited by 849

  14. Treatment-Resistant Bipolar Depression: A STEP-BD Equipoise Randomized Effectiveness Trial of Antidepressant Augmentation With Lamotrigine, Inositol, or Risperidone

    Authors: Andrew A. Nierenberg, Michael J. Ostacher, Joseph R. Calabrese, Terence A. Ketter, Lauren B. Marangell, David J. Miklowitz, Sachiko Miyahara, Mark S. Bauer, Michael E. Thase, Stephen R. Wisniewski, Gary S. Sachs, STEP-BD Investigators - American Journal of Psychiatry 2006 cited by 256

  15. Cariprazine in the treatment of acute mania in bipolar I disorder: A double-blind, placebo-controlled, Phase III trial

    Authors: Gary S. Sachs, William M. Greenberg, Anju Starace, Kaifeng Lu, Adam Ruth, I. Laszlovszky, György Németh, Suresh Durgam - Journal of Affective Disorders 2014 cited by 124

  16. Treatment effectiveness and tolerability outcomes that are most important to individuals with bipolar and unipolar depression

    Authors: Joshua D. Rosenblat, Gregory E. Simon, Gary S. Sachs, Ingrid Deetz, Allen Doederlein, Denisse DePeralta, Mary Mischka Dean, Roger S. McIntyre - Journal of Affective Disorders 2018 cited by 89

  17. Cariprazine for the Adjunctive Treatment of Major Depressive Disorder in Patients With Inadequate Response to Antidepressant Therapy

    Authors: Robert Riesenberg, Paul Yeung, Ludmyla Rekeda, Gary S. Sachs, Majid Kerolous, Maurizio Fava - The Journal of Clinical Psychiatry 2023 cited by 21

  18. A Double-Blind Placebo-Controlled Study of Lamotrigine Monotherapy in Outpatients With Bipolar I Depression

    Authors: Joseph R. Calabrese, Charles L. Bowden, Gary S. Sachs, John A. Ascher, Eileen Monaghan, G. David Rudd, The Lamictal 602 Study Group - The Journal of Clinical Psychiatry 1999 cited by 1,061

  19. Double-Blind, Placebo-Controlled Comparison of Imipramine and Paroxetine in the Treatment of Bipolar Depression

    Authors: Charles B. Nemeroff, Dwight L. Evans, L. Gyulai, Gary S. Sachs, Charles L. Bowden, I. Gergel, Rosemary Oakes, Cornelius D. Pitts - American Journal of Psychiatry 2001 cited by 403

  20. The Texas Implementation of Medication Algorithms

    Authors: Trisha Suppes, Ellen B. Dennehy, Robert M. A. Hirschfeld, Lori L. Altshuler, Charles L. Bowden, Joseph R. Calabrese, M. Lynn Crismon, Terence A. Ketter, Gary S. Sachs, Alan C. Swann, Texas Consensus Conference Panel on Medication Treatment of Bipolar Disorder - The Journal of Clinical Psychiatry 2005 cited by 330

  21. Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia

    Authors: Hader Mansour, Michael E. Talkowski, Joel Wood, Kodavali V. Chowdari, Lora McClain, Konasale M. Prasad, Debra M. Montrose, Andrea Fagiolini, Edward S. Friedman, Michael H. Allen, Charles L. Bowden, Joseph R. Calabrese, Rif S. El‐Mallakh, Michael Escamilla, Stephen V. Faraone, Mark D. Fossey, L. Gyulai, Jennifer M. Loftis, Péter Hauser, Terence A. Ketter, Lauren B. Marangell, David J. Miklowitz, Andrew A. Nierenberg, Jayendra K. Patel, Gary S Sachs, Pamela Sklar, Jordan W. Smoller, Nan M. Laird, Matcheri S. Keshavan, Michael E. Thase, David Axelson, Boris Birmaher, David A. Lewis, T. H. Monk, Ellen Frank, David J. Kupfer, Bernie Devlin, Vishwajit L. Nimgaonkar - Bipolar Disorders 2009 cited by 162

  22. Anxiety Disorder Comorbidity in Bipolar Disorder Patients: Data From the First 500 Participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

    Authors: Naomi M. Simon, Michael W. Otto, Stephen R. Wisniewski, Mark D. Fossey, Kemal Sagduyu, Ellen Frank, Gary S. Sachs, Andrew A. Nierenberg, Michael E. Thase, Mark H. Pollack, for the STEP-BD Investigators - American Journal of Psychiatry 2004 cited by 561

  23. Randomized, Placebo-Controlled Trial of Olanzapine as Maintenance Therapy in Patients With Bipolar I Disorder Responding to Acute Treatment With Olanzapine

    Authors: Mauricio Tohen, Joseph R. Calabrese, Gary S. Sachs, Michael Banov, Holland C. Detke, Richard C. Risser, Robert W. Baker, James C.-Y. Chou, Charles L. Bowden - American Journal of Psychiatry 2006 cited by 316

  24. Cross-Disorder Genomewide Analysis of Schizophrenia, Bipolar Disorder, and Depression

    Authors: Jie Huang, Roy H. Perlis, Phil H. Lee, A. John Rush, Maurizio Fava, Gary S. Sachs, Jeffrey Lieberman, Steven P. Hamilton, Patrick F. Sullivan, Pamela Sklar, Shaun Purcell, Jordan W. Smoller - American Journal of Psychiatry 2010 cited by 216